Literature DB >> 30758104

Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.

Hong Kyu Kim1, Dawon Park2, Hoon Yub Kim2.   

Abstract

BACKGROUND: Transoral approach for thyroidectomy draws attention recently among the thyroid surgeons, with the merits of cosmetic outcomes and minimal flap dissection. The aim of this study is to demonstrate the details and the steps of transoral robotic thyroidectomy.
METHODS: We made three incisions in the gingival-buccal sulcus for three 8-mm intraoral ports: one inverted U-shaped 1-cm midline incision approximately 2 cm above the frenulum, and two 0.5-cm lateral incisions near the commissure of lips. An additional 8-mm axilla port was inserted for countertraction and later drain insertion.
RESULTS: Right thyroid lobectomy, ipsilateral central neck dissection, and left thyroid lobectomy were performed with preserving recurrent laryngeal nerves and parathyroid glands. There was no development of transient or permanent hypoparathyroidism, vocal cord palsy, postoperative bleeding, or surgical site infection.
CONCLUSION: Transoral robotic total thyroidectomy and ipsilateral central neck dissection using the da Vinci Xi Surgical System are feasible and safe.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  remote-access thyroidectomy; robotic thyroidectomy; thyroid carcinoma; transoral thyroidectomy

Year:  2019        PMID: 30758104     DOI: 10.1002/hed.25661

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

Review 1.  Transoral thyroid and parathyroid surgery via the vestibular approach-a 2020 update.

Authors:  Jonathon O Russell; Zeyad T Sahli; Mohammad Shaear; Christopher Razavi; Khalid Ali; Ralph P Tufano
Journal:  Gland Surg       Date:  2020-04

2.  Pictorial essay of vestibular incision outcomes from transoral endoscopic thyroidectomy.

Authors:  Daqi Zhang; Yantao Fu; Le Zhou; Tie Wang; Nan Liang; Jiao Zhang; Gaofeng Xue; Gianlorenzo Dionigi; Hui Sun
Journal:  Langenbecks Arch Surg       Date:  2021-03-15       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.